Drug intelligence / Profile preview

NkBiome

Development stage: Unknown
Lead developer: Naked Biome
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Topical

Overview

NkBiome is a microbiome-based probiotic therapy developed by Naked Biome for the treatment of inflammatory skin conditions, including acne, eczema, psoriasis, and rosacea. The therapy involves the topical application of beneficial microbial strains to modulate the skin's microbiome, specifically targeting and reducing pathogenic bacteria implicated in disease pathogenesis. For acne, the therapy aims to displace virulent strains of *Cutibacterium acnes* with health-associated strains. The development is guided by sequencing-derived microbial signatures to restore a healthy skin ecosystem. The lead program for acne has completed a Phase 1b clinical trial, demonstrating safety and early trends in efficacy.

Other names: NkBiome Probiotic/Microbiome Therapy

Beyond the preview

Go deeper on NkBiome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NkBiome.

Explore the full profile